Biomind Labs Inc (BMND) — Capital Reinvestment Ratio

Latest as of June 2021: 0.21x

Biomind Labs Inc (BMND) has a Capital Reinvestment Ratio of 0.21x as of June 2021, meaning it reinvests 0% of its operating cash flow (CA$107.06K) in capital expenditures (CA$22.30K). See BMND equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.21x

Capex / Operating Cash Flow

Operating Cash Flow

CA$107.06K

CAD

Capital Expenditures

CA$22.30K

CAD

Data as of

Jun 2021

Most recent filing

Annual Capital Reinvestment Ratio for Biomind Labs Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Biomind Labs Inc from None to None. For live market cap and broader valuation context, see Biomind Labs Inc market capitalisation.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow